Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, China.
Department of Orthopedics, Lianshui County People's Hospital, Huaian, China.
J Cell Biochem. 2018 Nov;119(11):8743-8749. doi: 10.1002/jcb.27470. Epub 2018 Aug 30.
Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) signaling plays important physiological roles in bone homeostasis by regulating multiple steps of osteoblast differentiation as well as its activity. However, its potential role in osteocytes has not been explored. In this study, we deleted Raptor, a specific and essential component of mTORC1, in osteocytes using Dmp1-Cre. Deletion of Raptor in osteocytes did not affect bone development and growth, but caused compartment-specific effects on bone mass. Osteocyte-specific deletion of Raptor had no obvious effect on cortical bone compartments, but led to increased trabecular bone mass. Mechanistically, Raptor deletion resulted in decreased bone resorption without altering bone formation activity. Thus, our study revealed an unexpected role of osteocyte-intrinsic mTORC1 signaling in limiting trabecular bone mass, suggesting that osteocyte-specific inhibition of mTORC1 may be used as a novel approach to treatment of osteoporosis.
雷帕霉素靶蛋白(mTOR)复合物 1(mTORC1)信号通路通过调节成骨细胞分化的多个步骤及其活性,在骨稳态中发挥重要的生理作用。然而,其在骨细胞中的潜在作用尚未被探索。在这项研究中,我们使用 Dmp1-Cre 在骨细胞中特异性缺失 mTORC1 的一个特定且必需的组成部分 Raptor。骨细胞中 Raptor 的缺失不影响骨的发育和生长,但对骨量有特定的隔室效应。骨细胞特异性 Raptor 缺失对皮质骨隔室没有明显影响,但导致小梁骨量增加。从机制上讲,Raptor 缺失导致骨吸收减少而不改变骨形成活性。因此,我们的研究揭示了骨细胞内源性 mTORC1 信号在限制小梁骨量方面的意外作用,表明骨细胞特异性抑制 mTORC1 可能被用作治疗骨质疏松症的新方法。